The Aesthetics Licensing Scheme: What Your Clinic Needs to Know

If you spend any time in practitioner groups, you will have seen the posts. Licensing is coming in July. You will need a licence to inject by next year. Non-medics are being banned. Some of it is close, much of it is muddled, and a surprising amount is simply wrong.

Here is the position as it actually stands: what the government has published, what is genuinely law today, and what is still only a proposal. One thing up front: as of July 2026 there is no licensing scheme in force in England, no licence to apply for, and no confirmed start date. If a course or a consultant tells you that registration becomes mandatory this year, ask them for the legislation. There isn't any.

Where the law actually stands

The legal foundation was laid in 2022. Section 180 of the Health and Care Act 2022 gave the government the power to create a licensing scheme for non-surgical cosmetic procedures in England: a personal licence for practitioners and a premises licence for the places they work from, both administered by local authorities. But a power is not a scheme. Regulations have to be made under it before anything changes, and none have been made yet.

In late 2023 the Department of Health and Social Care consulted on how the scheme should work and received 11,848 responses. The government's answer arrived on 7 August 2025, and it is the most important document in aesthetics regulation right now. It confirmed the scheme is going ahead, and it confirmed the shape it will take.

The three tiers, explained

The confirmed model is a traffic-light system that sorts procedures by risk:

• Green (lower risk). Proposed examples include microneedling, superficial peels and light-based facial treatments. Open to any licensed practitioner who meets the agreed standards.
• Amber (medium risk). Proposed to include botulinum toxin and facial dermal fillers. Regulated healthcare professionals who meet the standards could perform these independently. Non-healthcare practitioners would need a licence and oversight from a named regulated healthcare professional.
• Red (highest risk). Procedures aimed at augmenting the breast, buttocks or genitals with dermal fillers, including the so-called liquid BBL. These will sit outside the local licence altogether and become CQC-regulated activities, restricted to suitably qualified regulated healthcare professionals working for CQC-registered providers.

Treat every tier placement as proposed. The government's own response says further work is required to determine where specific procedures will sit. The direction is settled; the detail is not.

One more signal worth noting: the response cites joint professional guidance from October 2024 stating that augmenting the breast, buttocks or genitals with dermal fillers or grafted fat is considered a surgical procedure. The era of the liquid BBL being treated like a beauty treatment is ending.

What happens first, and when

The government has been explicit about the order. The red tier comes first. Following the death of Alice Webb in 2024 after a liquid BBL, ministers committed to prioritising restrictions on the highest-risk procedures ahead of everything else, with enforcement through the CQC and financial penalties for those who break the rules.

Parliament is applying pressure. In February 2026 the Women and Equalities Committee called for high-harm procedures to be restricted immediately, without further consultation, and for a licensing system to be in place within this Parliament. In June 2026 the health minister responded that a consultation on draft regulations for the highest-risk procedures was planned for June, and repeated the commitment to implement licensing in the current Parliament. At the time of writing that consultation had not yet appeared on gov.uk, and the committee's chair had publicly criticised the delay.

The local authority licence for everyday clinic work, botulinum toxin and facial fillers included, comes after that: further public consultations on training standards, hygiene, insurance and fees, then Parliamentary approval, then implementation. No date has been set. Realistically, clinics have time. But the clinics that will find licensing painless are the ones already run as if it were here.

Scotland, Wales and Northern Ireland

The English scheme is England-only, and the rest of the UK is on different tracks:

• Scotland is ahead. The Non-surgical Procedures and Functions of Medical Reviewers (Scotland) Act 2026 received Royal Assent on 12 May 2026 after passing unopposed. It is not yet in force; commencement regulations are still required, and sector reporting anticipates a start around September 2027.
• Wales has run mandatory special procedures licensing since November 2024, but it covers acupuncture, piercing, electrolysis and tattooing including semi-permanent make-up. Botox and dermal fillers are not part of the Welsh scheme.
• Northern Ireland has no licensing scheme and none in progress; the Department of Health's review of the sector is paused. Note that the under-18 injectables ban is England-only law too.

The rules already in force

While the scheme is pending, several hard rules already apply. These are where clinics actually get caught out today.

The under-18 ban

Since 1 October 2021 it has been a criminal offence in England to administer botulinum toxin or injectable cosmetic fillers to anyone under 18 for cosmetic purposes, even with parental consent. The offence extends to the business that books the appointment. Robust age verification is not optional, and the planned licensing scheme is set to widen the under-18 restriction to everything it licenses.

Advertising

Botulinum toxin is a prescription-only medicine and cannot be advertised to the public: not on your website, not in social posts, not in hashtags or veiled names. The ASA runs an active enforcement notice with automated monitoring and refers repeat offenders to the MHRA or their professional regulator. You may advertise a consultation for lines and wrinkles where toxin is one possible option. Separately, since May 2022 cosmetic-intervention advertising must not be directed at under-18s.

Face-to-face prescribing

Remote prescribing for cosmetic injectables has been prohibited for doctors by the GMC since 2012, and since 1 June 2025 the Nursing and Midwifery Council requires nurse and midwife prescribers to consult face-to-face before prescribing for non-surgical cosmetic procedures. If your prescriber has not personally seen the patient, you do not have a compliant prescription.

How to get licence-ready now

The August 2025 response confirmed that licence holders will need to meet standards on safety, training and insurance. The specifics await further consultation, but every version of this scheme rewards the same preparation:

• Map your treatment list against the proposed tiers and write down your scope of practice: what you offer, what you do not, and what you refer on.
• Get records to inspection standard. Full consultation notes, a documented face-to-face prescriber assessment, signed consent that covers the material risks, and before-and-after photos taken with explicit consent that explains how they are stored and used.
• Keep training evidence per treatment, not just per person. No qualification has been formally mandated yet, whatever a course provider may imply, so hold certificates for accredited training in every modality you offer.
• Check your insurance matches your treatment list and that your training evidence satisfies your insurer. Appropriate indemnity and insurance arrangements are confirmed as a condition of the future licence.
• Consider the JCCP practitioner register, which is accredited by the Professional Standards Authority. It remains voluntary, not a legal requirement, but it is a credibility marker aligned with where regulation is heading.
• Be complications-ready. An in-date emergency kit, written adverse-event protocols, and suspected toxin reactions reported through the MHRA Yellow Card scheme.
• In London, check your borough's existing special treatment licence rules for treatments such as laser and IPL. That regime is already live and entirely separate from the national scheme.

Good records will carry you through

Strip away the politics and the licensing scheme asks one question of your clinic: can you evidence what you do? Who treated which patient, with what product, on whose prescription, after what assessment, with what consent, and with what training and insurance behind it. Clinics that can answer that from one system, in minutes, will sail through licensing whenever it lands. Clinics running on paper forms, WhatsApp threads and memory will not enjoy the transition.

That is the job CallidusOS was built for: consultation records, consent, prescribing sign-off and audit trails kept tidy, retained and ready, so your clinic is licence-ready before the licence exists. See how it works.

This article is general information for UK aesthetic practitioners, correct at the time of writing on 3 July 2026, and is not legal, medical or regulatory advice. This area is moving quickly: check gov.uk for the latest position and confirm your obligations with the relevant regulator and your professional indemnity provider.